1996
DOI: 10.1093/rheumatology/35.2.139
|View full text |Cite
|
Sign up to set email alerts
|

The Ten-Year Mortality in Behçet's Syndrome

Abstract: We surveyed the 10-yr mortality among 152 Behçet's syndrome (BS) patients who had registered at a BS out-patient clinic and compared it to the expected mortality in the general population. Information on mortality was available in 79% of the study group, among whom six patients (all males) had died. The observed mortality of two patients in the 15-24 yr age bracket was significantly above that expected in the general population. BS is a cause of increased mortality in the young male patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
71
0
10

Year Published

1997
1997
2013
2013

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 127 publications
(83 citation statements)
references
References 3 publications
2
71
0
10
Order By: Relevance
“…Seyahi and Yazici for their interest in our work regarding the interplay between BD and pregnancy and for bringing new elements to the discussion. A reduction in BD activity associated with the passage of time has been previously reported (1)(2)(3)(4)(5). Seyahi and Yazici suggest that shorter disease duration might account for the lower frequency of BD flares that we observed in our patients during pregnancy.…”
Section: Replysupporting
confidence: 80%
“…Seyahi and Yazici for their interest in our work regarding the interplay between BD and pregnancy and for bringing new elements to the discussion. A reduction in BD activity associated with the passage of time has been previously reported (1)(2)(3)(4)(5). Seyahi and Yazici suggest that shorter disease duration might account for the lower frequency of BD flares that we observed in our patients during pregnancy.…”
Section: Replysupporting
confidence: 80%
“…Other signs of BD such as arthralgias and epididymitis were observed in 37.5% and 3.1% of patients, respectively. Vascular involvement was frequently present (62.5%), with recurrent or multiple venous thrombosis in 38 Neurologic features of BD. The main neurologic features of CVT are shown in Table 2.…”
Section: Characteristics Of Bdmentioning
confidence: 99%
“…La ciclofosfamida se recomienda mensual EV en dosis ajustada por superficie corporal. Dependiendo de la respuesta clínica se puede discontinuar el rev Med Chile 2013; 141: 922-926 esteroide y mantener ciclofosfamida, por lo menos, durante 1 año 22 . Se han descrito casos, con la terapia señalada, de estabilización y hasta de regresión de los aneurismas pulmonares 23 .…”
Section: Discussionunclassified